Transcatheter arterial embolization therapy for a massive polycystic liver in autosomal dominant polycystic kidney disease patients

Journal of Korean Medical Science

Volumn 24, Issue 1, 2009, Pages 57-61

  Park, Hayne Cho ^a   Kim, Chi Weon ^a   Ro, Han ^a   Moon, Ju Young ^b   Oh, Kook Hwan ^a   Kim, Yonsu ^a   Lee, Jung Sang ^a   Yin, Yong Hu ^a   Jae, Hwan Jun ^a   Chung, Jin Wook ^a   Ahn, Curie ^a,c   Hwang, Young Hwan ^d  

^a Seoul National University College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d Eulji General Hospital   (South Korea)

Author keywords

Autosomal dominant; Embolization; Polycystic kidney; Therapeutic

Indexed keywords

POLYVINYL ALCOHOL;

AGED; ARTICLE; ARTIFICIAL EMBOLISM; CASE REPORT; CATHETERIZATION; COMPUTER ASSISTED TOMOGRAPHY; CYST; FEMALE; HEPATIC ARTERY; HUMAN; INSTRUMENTATION; KIDNEY POLYCYSTIC DISEASE; LIVER; LIVER DISEASE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

AGED; CATHETERIZATION; CYSTS; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATIC ARTERY; HUMANS; LIVER; LIVER DISEASES; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; POLYVINYL ALCOHOL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 65649137649     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.1.57     Document Type: Article

References (10)

1. Hwang DY, Ahn C, Lee JG, Lee EJ, Cho JT, Hwang YH, Eo HS, Chae HJ, Kim SJ, Kim Y, Han JS, Kim S, Lee JS, Kim SH. Hepatic complications in autosomal-dominant polycystic kidney disease. 20th Annual Spring Conference of Korean Society of Nephrology. Seoul, Korea 2000; 19: S306.
2. Chauveau D, Fakhouri F, Grunfeld JP. Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol 2000; 11: 1767-75.
3. Erdogan D, van Delden OM, Rauws EA, Busch OR, Lameris JS, Gouma DJ, van Gulik TM. Results of percutaneous sclerotherapy and surgical treatment in patients with symptomatic simple liver cysts and polycystic liver disease. World J Gastroenterol 2007; 13: 3095-100.
4. Robinson TN, Stiegmann GV, Everson GT. Laparoscopic palliation of polycystic liver disease. Surg Endosc 2005; 19: 130-2.
5. Arnold HL, Harrison SA. New advances in evaluation and management of patients with polycystic liver disease. Am J Gastroenterol 2005; 100: 2569-82.
6. Takei R, Ubara Y, Hoshino J, Higa Y, Suwabe T, Sogawa Y, Nomura K, Nakanishi S, Sawa N, Katori H, Takemoto F, Hara S, Takaichi K. Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2007; 49: 744-52.
7. Ubara Y, Takei R, Hoshino J, Tagami T, Sawa N, Yokota M, Katori H, Takemoto F, Hara S, Takaichi K. Intravascular embolization therapy in a patient with an enlarged polycystic liver. Am J Kidney Dis 2004; 43: 733-8.
8. Ubara Y. New therapeutic option for autosomal dominant polycystic kidney disease patients with enlarged kidney and liver. Ther Apher Dial 2006; 10: 333-41.
9. Sherstha R, McKinley C, Russ P, Scherzinger A, Bronner T, Showalter R, Everson GT. Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology 1997; 26: 1282-6.
10. Torres VE. Treatment of polycystic liver disease: one size does not fit all. Am J Kidney Dis 2007; 49: 725-8.